Cargando…

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)

Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first enzyme of the hexosamine biosynthetic pathway. It transfers an amino group from glutamine to fructose-6-phosphate to yield glucosamine-6-phosphate, thus providing the precursor for uridine diphosphate N-acetylglucosamine (UDP-GlcNAc)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiushi, Müller, Juliane S., Pang, Poh-Choo, Laval, Steve H., Haslam, Stuart M., Lochmüller, Hanns, Dell, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693256/
https://www.ncbi.nlm.nih.gov/pubmed/26501342
http://dx.doi.org/10.3390/biom5042758
_version_ 1782407351066689536
author Chen, Qiushi
Müller, Juliane S.
Pang, Poh-Choo
Laval, Steve H.
Haslam, Stuart M.
Lochmüller, Hanns
Dell, Anne
author_facet Chen, Qiushi
Müller, Juliane S.
Pang, Poh-Choo
Laval, Steve H.
Haslam, Stuart M.
Lochmüller, Hanns
Dell, Anne
author_sort Chen, Qiushi
collection PubMed
description Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first enzyme of the hexosamine biosynthetic pathway. It transfers an amino group from glutamine to fructose-6-phosphate to yield glucosamine-6-phosphate, thus providing the precursor for uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) synthesis. UDP-GlcNAc is an essential substrate for all mammalian glycosylation biosynthetic pathways and N-glycan branching is especially sensitive to alterations in the concentration of this sugar nucleotide. It has been reported that GFPT1 mutations lead to a distinct sub-class of congenital myasthenic syndromes (CMS) termed “limb-girdle CMS with tubular aggregates”. CMS are hereditary neuromuscular transmission disorders in which neuromuscular junctions are impaired. To investigate whether alterations in protein glycosylation at the neuromuscular junction might be involved in this impairment, we have employed mass spectrometric strategies to study the N-glycomes of myoblasts and myotubes derived from two healthy controls, three GFPT1 patients, and four patients with other muscular diseases, namely CMS caused by mutations in DOK7, myopathy caused by mutations in MTND5, limb girdle muscular dystrophy type 2A (LGMD2A), and Pompe disease. A comparison of the relative abundances of bi-, tri-, and tetra-antennary N-glycans in each of the cell preparations revealed that all samples exhibited broadly similar levels of branching. Moreover, although some differences were observed in the relative abundances of some of the N-glycan constituents, these variations were modest and were not confined to the GFPT1 samples. Therefore, GFPT1 mutations in CMS patients do not appear to compromise global N-glycosylation in muscle cells.
format Online
Article
Text
id pubmed-4693256
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46932562016-01-07 Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1) Chen, Qiushi Müller, Juliane S. Pang, Poh-Choo Laval, Steve H. Haslam, Stuart M. Lochmüller, Hanns Dell, Anne Biomolecules Article Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first enzyme of the hexosamine biosynthetic pathway. It transfers an amino group from glutamine to fructose-6-phosphate to yield glucosamine-6-phosphate, thus providing the precursor for uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) synthesis. UDP-GlcNAc is an essential substrate for all mammalian glycosylation biosynthetic pathways and N-glycan branching is especially sensitive to alterations in the concentration of this sugar nucleotide. It has been reported that GFPT1 mutations lead to a distinct sub-class of congenital myasthenic syndromes (CMS) termed “limb-girdle CMS with tubular aggregates”. CMS are hereditary neuromuscular transmission disorders in which neuromuscular junctions are impaired. To investigate whether alterations in protein glycosylation at the neuromuscular junction might be involved in this impairment, we have employed mass spectrometric strategies to study the N-glycomes of myoblasts and myotubes derived from two healthy controls, three GFPT1 patients, and four patients with other muscular diseases, namely CMS caused by mutations in DOK7, myopathy caused by mutations in MTND5, limb girdle muscular dystrophy type 2A (LGMD2A), and Pompe disease. A comparison of the relative abundances of bi-, tri-, and tetra-antennary N-glycans in each of the cell preparations revealed that all samples exhibited broadly similar levels of branching. Moreover, although some differences were observed in the relative abundances of some of the N-glycan constituents, these variations were modest and were not confined to the GFPT1 samples. Therefore, GFPT1 mutations in CMS patients do not appear to compromise global N-glycosylation in muscle cells. MDPI 2015-10-16 /pmc/articles/PMC4693256/ /pubmed/26501342 http://dx.doi.org/10.3390/biom5042758 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Qiushi
Müller, Juliane S.
Pang, Poh-Choo
Laval, Steve H.
Haslam, Stuart M.
Lochmüller, Hanns
Dell, Anne
Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title_full Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title_fullStr Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title_full_unstemmed Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title_short Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
title_sort global n-linked glycosylation is not significantly impaired in myoblasts in congenital myasthenic syndromes caused by defective glutamine-fructose-6-phosphate transaminase 1 (gfpt1)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693256/
https://www.ncbi.nlm.nih.gov/pubmed/26501342
http://dx.doi.org/10.3390/biom5042758
work_keys_str_mv AT chenqiushi globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT mullerjulianes globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT pangpohchoo globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT lavalsteveh globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT haslamstuartm globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT lochmullerhanns globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1
AT dellanne globalnlinkedglycosylationisnotsignificantlyimpairedinmyoblastsincongenitalmyasthenicsyndromescausedbydefectiveglutaminefructose6phosphatetransaminase1gfpt1